Pressefach

AUSSENDER



QIAGEN N.V.
Ansprechpartner: Investor Relations
Tel.: +31 7735566 - 00
E-Mail: ir@qiagen.com
Pressefach

Schlagwörter

QIAGEN N.V.
Stimmrechtsanteile
Voting rights
15.11.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
15.11.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
08.11.2024 - 22:35 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
08.11.2024 - 12:15 | QIAGEN N.V.
Release of a capital market information
08.11.2024 - 12:15 | QIAGEN N.V.
Third Country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]
05.11.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
31.10.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
31.10.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
31.10.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
25.10.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
23.10.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
23.10.2024 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
18.10.2024 - 22:15 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
18.10.2024 - 22:15 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
18.10.2024 - 22:15 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
Artikel 1 - 15
weiter
|
99.112 Abonnenten
|
221.743 Meldungen
|
90.622 Pressefotos
|
Folgen Sie uns auf Twitter
Top